
OnabotulinumtoxinA for Migraine: What You Need to Know
HeadWise
00:00
Exploring the Effectiveness of OnabotulinumtoxinA for Chronic Migraine Treatment
This chapter examines the role of OnabotulinumtoxinA in treating chronic migraines, focusing on its FDA approval and supporting research that showcases reduced headache frequency. It also addresses the interplay between Onabot and CGRP monoclonal antibodies, highlighting potential benefits of their combined use in enhancing patient outcomes.
Play episode from 02:14
Transcript


